Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

Edit for correction: The ASCO poster presented May 30 said Cohort 11 (10 on the poster) was still ongoing. Shapiro stated that 2 of the 3 were still in the dosing cycle. So, as of end of May Cohort 11 had not yet finished. Just before that, the trial was expanded by 20 more patients without explanation of how those final 20 would enroll.

http://cellceutix.com/wp-content/uploads/2014/06/A-phase-1-dose-escalation-safety-pharmacokinetic-pharmacodynamic-study-of-thioureidobutyronitrile-a-novel-p53-targeted-therapy-in-patients-with-advanced-solid-tumors..pdf